Kinex Pharmaceuticals Initiates A Phase 2 Clinical Trial Of KX2-391 In Patients With Prostate Cancer

Kinex Pharmaceuticals opened a Phase 2 clinical trial to evaluate the safety and efficacy of KX2- 391 in patients with bone-metastatic, castrate- resistant prostate cancer (CRPC) who have not had prior chemotherapy. Source: General Cancer News Articles Provided by Cancer Compass

Initiation Of Phase I Combination Clinical Trial Of Brentuximab Vedotin SGN-35 For Front-Line Hodgkin Lymphoma
Merrimack Pharmaceuticals Initiates Enrollment In A Phase 1/2 Combination Study Of MM-121 And Tarceva In Patients With Non-Small Cell Lung Cancer
ArQule Announces Initiation of Clinical Programs with ARQ 197 in Germ Cell Tumors and Colorectal Cancer
ARIAD Announces Recommendation Of Following Second Interim Analysis Of Phase 3 Succeed Trial Of Oral Ridaforolimus, an Investigational mTOR Inhibitor, in Metastatic Sarcomas
OSI Pharmaceuticals Announces That RADIANT, An International Phase III Tarceva Adjuvant Trial In Non-Small Cell Lung Cancer, Completes Enrollment
Synta Announces Positive Results In Phase 2 NSCLC Trial For STA-9090 Support Advancing Trial To Second Stage
GTx Announces Top Line Results Of Phase III Clinical Trial Evaluating Toremifene 20 mg For The Prevention Of Prostate Cancer In Men With High Grade PIN
Denosumab Demonstrated Superiority Over Zometa In Pivotal Phase 3 Head-To-Head Trial In Prostate Cancer Patients With Bone Metastases
Researchers At National Institutes Of Health Have Published New Data On Prostate Cancer
News Note: Addition of Cetuximab to Standard Chemotherapy in Early-Stage Colon Cancer Shows No Benefit in Phase 3 Clinical Trial
Multiple Myeloma Research Consortium MMRC Initiates Phase Ib/II Clinical Trial Of Treanda In Combination With Revlimid And Dexamethasone In Patients With Relapsed Multiple Myeloma
Late-Stage Ovarian Cancer Shows Promise In Two-Drug Phase I Trial
Medifocus, Inc. Announces Food And Drug Administration FDA Update For Its Pivotal Phase III Clinical Trial For Treatment Of Breast Cancer: Files Response To Two Remaining Questions
Telormedix' TMX-101 Commences Clinical Trial For Bladder Cancer
Drug In New Class Of Targeted Therapies Shows Early Promise Against Blood-Related Cancers

Tags: Cancer, Clinical, Initiates, Kinex, KX2391, patients, Pharmaceuticals, Phase, Prostate, Trial
Posted in Cancer on | There are currently No Comments

Cancer Cure Books

Sponsored Links

Kinex Pharmaceuticals Initiates A Phase 2 Clinical Trial Of KX2-391 In Patients With Prostate Cancer

Related Posts:

Leave a Reply